Author

Bu-tuo Xu

Observed names: Bu-Tuo Xu, Butuo Xu

Institutions: Southwest Medical University, Affiliated Hospital of Southwest Medical University

Observed institutions: Southwest Medical University, Affiliated Hospital of Southwest Medical University

ORCID: 0000-0002-8623-3766

Observed ORCID: 0000-0002-8623-3766

OpenAlex ID: A5086816322

The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction

2023 · Ying An, Bu-tuo Xu, et al. · Cardiovascular Diabetology · 398

Targeting cell death in NAFLD: mechanisms and targeted therapies

2024 · Hui-li Xu, Sheng-rong Wan, et al. · Cell Death Discovery · 64

Bdh1 overexpression ameliorates hepatic injury by activation of Nrf2 in a MAFLD mouse model

2022 · Bu-tuo Xu, Fang-yuan Teng, et al. · Cell Death Discovery · 44

BDH1-mediated βOHB metabolism ameliorates diabetic kidney disease by activation of NRF2-mediated antioxidative pathway

2023 · Sheng-Rong Wan, Fang-Yuan Teng, et al. · Aging · 38

Maresin 1 Alleviates Diabetic Kidney Disease via LGR6‐Mediated cAMP‐SOD2‐ROS Pathway

2022 · Xinyue Li, Butuo Xu, et al. · Oxidative Medicine and Cellular Longevity · 29

BDH1 overexpression alleviates diabetic cardiomyopathy through inhibiting H3K9bhb-mediated transcriptional activation of LCN2

2025 · Bu-tuo Xu, Sheng-rong Wan, et al. · Cardiovascular Diabetology · 24

Sodium Butyrate Ameliorates Diabetic Kidney Disease Through Acss2/P300-Mediated Histone Butyrylation Pathway

2024 · Wei Huang, Xi Cheng, et al. · SSRN Electronic Journal · 1

Correction: BDH1 overexpression alleviates diabetic cardiomyopathy through inhibiting H3K9bhb-mediated transcriptional activation of LCN2

2026 · Bu-tuo Xu, Sheng-rong Wan, et al. · Cardiovascular Diabetology

Sodium Butyrate Ameliorates Diabetic Kidney Disease Partially Through ACSS2/P300-Mediated Histone Butyrylation Pathway

2025 · Xi Cheng, Tingting Zhou, et al. · Research Square

Works count: 9

Citation count: 598

H-index: 6

I10-index: 6